Merck & Co Inc (NYSE:MRK)
| 103.74 Delayed Data As of Dec 08 |  -0.14 / -0.13%Today’s Change | 99.14 Today|||52-Week Range 119.65 | -6.50% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 38.8B | 39.5B | 40.0B | 42.4B | |
| Cost of Goods Sold | 8.2B | 7.9B | 7.9B | 8.5B | ||
| Depreciation And Amortization | 6.4B | 5.4B | 4.6B | 4.5B | ||
| Operating Expenses | Gross Income | 24.2B | 26.1B | 27.4B | 29.4B | |
| General Expenses | 16.8B | 15.6B | 19.4B | 19.6B | ||
| Research And Development | 6.6B | 6.0B | 9.6B | 9.5B | ||
| Total Operating Expenses | 31.4B | 29.0B | 32.0B | 32.7B | ||
| Non-Operating Expenses | Operating Income | 7.4B | 10.5B | 8.0B | 9.8B | |
| Extraordinary Credit | 489.0M | -- | 3.0M | 302.0M | ||
| Extraordinary Charge | -1.9B | -6.1B | -1.7B | -1.3B | ||
| Pre-Tax Equity Earnings | 205.0M | 86.0M | 42.0M | 324.0M | ||
| Interest Expense On Debt | 675.0M | 693.0M | 756.0M | 772.0M | ||
| Other Expenses | -417.0M | 571.0M | 558.0M | 53.0M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 5.4B | 4.7B | 6.5B | 8.7B | |
| Income Taxes | -942.0M | -718.0M | -4.1B | -2.5B | ||
| Minority Interest | -17.0M | -21.0M | -24.0M | -27.0M | ||
| Net Income | 4.4B | 3.9B | 2.4B | 6.2B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 2.8B | 2.8B | 2.7B | 2.7B | |
| Shares To Calculate EPS Diluted | 2.8B | 2.8B | 2.7B | 2.7B | ||
| Earnings Per Share | EPS | $1.56 | $1.41 | $0.87 | $2.32 | |
| EPS Diluted | $1.56 | $1.41 | $0.87 | $2.32 | ||
